⌘K
Loading ticker…
Protagonist Therapeutics, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Protagonist Therapeutics, Inc (PTGX) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 67. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.6%, relative volume 3.36×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 70, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PTGX is in a stage 2 uptrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 17.1% / 36.9%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PTGX appears in 1 ETF as of Mar 2026: IJR at 0.40% weight, $372M notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.40% | $372M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PTGX Jan avg: 5.62% median: 3.50% win: 50% σ: 12.60% n: 4 2022-04-12 → 2026-05-29 | PTGX Feb avg: 13.88% median: 17.02% win: 75% σ: 10.56% n: 4 2022-04-12 → 2026-05-29 | PTGX Mar avg: 20.04% median: 21.56% win: 75% σ: 19.95% n: 4 2022-04-12 → 2026-05-29 | PTGX Apr avg: -17.70% median: -6.10% win: 0% σ: 25.23% n: 5 2022-04-12 → 2026-05-29 | PTGX May avg: 5.61% median: 3.60% win: 80% σ: 7.93% n: 5 2022-04-12 → 2026-05-29 | PTGX Jun avg: 8.94% median: 11.19% win: 75% σ: 14.29% n: 4 2022-04-12 → 2026-05-29 (current) | PTGX Jul avg: 0.38% median: 2.75% win: 50% σ: 23.25% n: 4 2022-04-12 → 2026-05-29 | PTGX Aug avg: 3.50% median: 5.90% win: 75% σ: 11.74% n: 4 2022-04-12 → 2026-05-29 | PTGX Sep avg: -0.44% median: 0.80% win: 50% σ: 12.13% n: 4 2022-04-12 → 2026-05-29 | PTGX Oct avg: 0.87% median: -1.02% win: 50% σ: 13.13% n: 4 2022-04-12 → 2026-05-29 | PTGX Nov avg: 8.23% median: 6.07% win: 50% σ: 14.15% n: 4 2022-04-12 → 2026-05-29 | PTGX Dec avg: 12.26% median: 11.48% win: 50% σ: 23.52% n: 4 2022-04-12 → 2026-05-29 |